Skip to main content
Clinical Trials/ISRCTN17837384
ISRCTN17837384Completed未知

An acute investigation into the relationship between genetic variation, digestion and blood glucose response upon consumption of carbohydrates

niversity College London (UCL) (UK)0 sites48 target enrollmentStarted: November 6, 2013Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
48

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Current inclusion criteria as of 10/03/2014:
  • 1. Healthy, non-smoking, men and women aged between 18-40 years old
  • 2. British participants who were born in the UK and who have four grandparents that were also born in the UK
  • Previous inclusion criteria:
  • Healthy, non-smoking, men and women, aged 18-40 years, of British ethnicity

Exclusion Criteria

  • Exclusion criteria identified during visit 1 using questionnaire:
  • 1. The subject is an employee of Unilever
  • 2. Medical history of myocardial infarction, angina, thrombosis, stroke, cancer or diabetes
  • 3. Medical history of eating disorders such as anorexia nervosa, bulimia, binge eating disorder
  • 4. Medical history of digestive dysfunction, or intestinal disease such as IBS and Crohn?s disease
  • 5. Medical history of pancreatitis (Acute, Chronic or Hereditary) and exocrine pancreatic insufficiency
  • 6. Alcohol intake exceeding a moderate intake (>28 units per week)
  • 7. Needle phobic, fear of blood and blood clotting disorders such as haemophilia
  • 8. Pregnant, breast-feeding and post-menopausal women
  • Exclusion criteria identified after visit 2, using genetic and health screening methods:
  • 1. Fasting plasma glucose > 6.0 mmol /L
  • 2. Fasting plasma insulin > 60 pmol/L
  • 3. Fasting plasma cholesterol > 7.8 mmol /L
  • 4. Body fat percentage < 8% or >25% for men and < 20% or >35% for women
  • 5. Body mass index (BMI) <18.5 or >25.5
  • 6. Blood pressure < 90/60 or >120/80
  • 7. Abnormal liver function
  • The following will be recorded but are not considered grounds for exclusion, as there is no evidence that this will cause adverse response or distress to the subjects, but it may be of interest.
  • 1. Diagnosed lactose intolerance
  • 2. Confirmed gluten sensitivity, including coeliac disease

Investigators

Sponsor
niversity College London (UCL) (UK)

Similar Trials

Postprandial effects of genetic variation... | Clinical Trial